• SinglePoint recently completed acquisitions of Convectium and DIGS Hydro
• The company offers an online payment solution through a partnership with First Bitcoin Capital
• Online payments and marketing services are available through SingleSeed.com

SinglePoint, Inc. (OTC: SING) revealed in a July 18, 2017, audio press release that it is now working with a cryptocurrency expert to lead an initiative to develop a payment solution designed for high risk customers. The company has grown from a full service mobile tech provider to a publicly traded holding company serving the cannabis market. Thanks to a joint venture with First Bitcoin Capital Corp., according to the audio press release (http://dtn.fm/K68cB), efforts to deliver a testable solution within 60 days are underway.

Helping to drive a consumer-first approach, the joint venture is expected to yield an easier transaction at the point of sale. In addition, two recent acquisitions are driving SinglePoint’s acquisition and growth strategy. One is DIGS Hydro, which now has two operating stores in Southern California and plans to open a third. The company, specializing in growing, cultivating and consulting in the cannabis industry, has seen growth in its first two quarters. The acquisition of Convectium, which manufactures and supplies the 710Shark oil filling machine, has been fulfilling as well.

In a recent podcast (http://dtn.fm/Mw9aP), Greg Lambrecht, CEO of SinglePoint, interviewed Wil Ralston, VP of sales and marketing. The two discussed how a new payment solution will avoid issues of purchasing cannabis products through banks, as well as the company’s presence in the OTC markets. Ralston also discussed the expansion of Convectium into a new office, with the addition of five new sales people and an operations specialist, and how it is driving the company’s acquisition phase and revenues.

SinglePoint is also developing an online marketing strategy, which involves selling products nationwide through the DIGS website – DIGSHydro.com. The recently acquired subsidiary received a significant purchase order in June to offer supplies and services to a major biomedical company. Payment solutions are already being offered through the online portal and subsidiary at SingleSeed.com, available now to cannabis retailers. It offers credit card processing, pay by text, cashless ATM, and point of banking services.

The company is also looking into additional acquisition options. It is planning to acquire a technology-driven delivery company and another that provides solar solutions to commercial cannabis growers. It has a presence in the solar industry in parts of Arizona, Texas, and southeast New York. In addition to payment processing, mobile messaging services are available, so companies can reach out to mobile subscribers with deals, coupons, and other notifications via SMS.

For more information, visit the company’s website at www.SinglePoint.com

Let us hear your thoughts: SinglePoint, Inc. Message Board

The Securities and Exchange Commission has issued a temporary trading suspension of First Bitcoin Capital Corp. (OTC: BITCF) shares because of concerns about the accuracy and adequacy of public information on the Canadian company.

The order took effect at 9:30 a.m. EDT last Thursday and terminates at 11:59 a.m. on September 7, 2017. The SEC cited concerns about the company, including the value of BITCF’s assets and its capital structure, in a news release accompanying the suspension order.

Shares of First Bitcoin Capital are traded over-the-counter and were last trading at $1.79 per share, according to Bloomberg. Shares had risen almost 7,000 percent this year prior to the suspension order. By contrast, the S&P 500 is up nine percent during the same time period.

“The Commission cautions broker-dealers, shareholders, and prospective purchasers that they should carefully consider the foregoing information along with all other currently available information and any information subsequently issued by the company,” the SEC noted in its statement.

First Bitcoin Capital management issued a notice to shareholders downplaying the 10-day suspension.

“The company has retained competent SEC counsel to work with the SEC to learn of any concerns beyond the over exuberant market for our shares such as our disclosures of assets and capital structure,” the company stated in its shareholder letter. “We believe that there is likely a misunderstanding or a simple clarification necessary and that it would have been better for the SEC to ask us for this information before taking such drastic action.”

According to its website, First Bitcoin Capital is a publicly-traded Canadian company engaged in various digital cryptocurrency-related business lines. It holds proprietary blockchain technologies and operates a digital currency exchange.

For more information, visit the company’s website at www.BitcoinCapitalCorp.com

• 19 patent applications filed in the United States and internationally (under the Patent Cooperation Treaty), with national filings in 44 countries
• Collaborative research and development agreement with Canada’s National Research Council to investigate opportunities associated with bioavailability enhancement of certain compounds, including those in cannabinoids, vitamins, NSAIDs and nicotine
• Out-licenses its patented technology to third party partners, with several deals signed or pending

When Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) researchers tackled the issue facing consumers of edible cannabinoids – poor absorption of the product’s bioactive compounds by the body’s gastrointestinal tract – an important statement led the way: bioavailability matters. The company realized that if hemp oil ingredients were infused within lipids found in popular foods, the common problems of bad taste, poor absorption in the body and lack of product variety could be solved.

Lexaria has since developed a superior method of lipid-delivery technology through a patented process that does this by infusing the beneficial elements of hemp oil to lipid molecules. Lexaria reminds consumers that it is not mixing hemp oil into a product; it is infusing organically sourced, high purity hemp oil inside the molecules of other ingredients to produce superior tasting and performing food and beverages, including premium teas, protein energy bars and hemp oil capsules formulated with ginseng and ginkgo for enhanced memory and focus.

Additionally, this technologically superior method of delivery is being considered for other products in demand by consumers, namely nicotine-based products. Lexaria’s method could remove many of the dangerous side effects of nicotine, although the patented molecular delivery technology for this product remains in its early stages (http://dtn.fm/c2VCP).

Lexaria is also seeking patents to use its lipophilic enhancement technology for tetrahydrocannabinol (THC) and other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs such as ibuprofen), nicotine and other molecules. New business-to-business relationships are on the horizon in the fields of vitamins, NSAIDs and nicotine delivery.

For more information, visit the company’s website www.LexariaEnergy.com

Let us hear your thoughts: Lexaria Bioscience Corp. Message Board

• An early mover in the Canadian cannabis space
• Serving Canada’s most populous province
• New funding deal signed for $15 million at $2.25 per share

As befits its status as a first mover in the Canadian cannabis space, ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) is racing ahead with plans to supply the medical marijuana needs of Canada’s most populous province. Construction plans at its Kimmett facility in the third quarter of 2017 remain on schedule, and the previously announced plans for a 71,000 square foot phase 1 project have been expanded to 100,000 square feet. The company recently signed a funding deal that prices the business well above market valuation. It appears that ABcann is one MMJ outfit that the smart money is betting on.

ABcann was one of the earliest players to apply for a cannabis grower’s license in Canada, which was granted in March 2014, well before the current Access to Cannabis for Medical Purposes Regulations (ACMPR) were implemented on August 24, 2016. That early start has advanced ABcann much further along the learning curve than subsequent licensees. In addition, having worked in collaboration with the University of Guelph in Ontario, Canada, to study the growing process, ABcann’s expertise is superior to most other LPs. It has developed state-of-the-art growing technology that produces high yields and consistency in its produce as it scales up. Also, somewhat like in retail, where location is a major determinant of success, ABcann’s location is fortuitous. Its operations are situated in Canada’s most populous province of Ontario, which, with 13.5 million people, accounts for close to 40 percent of Canada’s total population.

Knowledge of the growing process is particularly important if a licensed producer is going to scale up successfully. An essential requirement of medical marijuana is consistency. The product must be relied on to deliver a standardized quantity and quality of active ingredients every time it’s taken. Imagine the peril to patients of undergoing prescribed regimens of a medication with psychoactive properties where the dosages vary randomly.

Quality is obviously a crucial issue and, indeed, was one of the reasons that ABcann was founded by Ken Clement. ABcann’s mission, he has said, is “to deliver consistent, standardized medicinal cannabis that the public and patients can consistently rely on” (http://dtn.fm/wGg26). Now, ABcann is able to produce an organically grown, pesticide-free, standardized product with a growing system that controls air quality, carbon dioxide and oxygen levels, water quality and volume, light spectrum and cycles, temperature and humidity, plant nutrition and the curing process.

Earlier this month, ABcann announced completion of the initial funding phase of its partnership with Cannabis Wheaton (TSX.V: CBW). Under the deal, CBW has purchased $15 million worth of ABcann common shares at $2.25 per share. The cash forms part of a larger phased investment by Cannabis Wheaton that is expected to fund an additional 50,000 square feet of production space, capable of producing 35,000 kilograms of product per year, at ABcann’s second facility. This expansion comes alongside ABcann’s existing construction plans for a 100,000 square foot facility at its Kimmett property in Napanee, Ontario.

Since debuting on the Toronto Venture Stock Exchange at $1.00, ABcann stock has traded down a little, but, as recent events indicate, it may be a diamond in the rough. The Cannabis Wheaton deal valued the stock, which currently trades at C$0.87, at $2.25.

For more information, visit the company’s website at www.ABcann.ca

Let us hear your thoughts: ABcann Global Corp. Message Board

• About 1,175,000 residential projects were completed in July, according to the U.S. Census Bureau
• Bollente’s trutankless water heaters are 99 percent efficient and provide hot water all the time
• The systems can run maintenance-free for 20 years or more, reducing demand on landfills

The U.S. housing construction market remained robust in July 2017. A seasonal adjusted rate of 1,223,000 for building permits was reported for the month, and privately-owned housing starts were adjusted to 1,155,000. There were 1,175,000 housing completions for private residences, according to the United States Census Bureau (http://dtn.fm/w6ZO3). Construction trends of energy efficient, water saving multi-family dwellings in warm climates are fueling the demand for tankless water heaters like the revolutionary trutankless line from Bollente Companies, Inc. (OTC: BOLC). This comes as an estimated 57 percent of traditional U.S. water heaters are close to or have surpassed their expected age of failure.

The trutankless water heater line from Bollente is more compact and efficient than traditional heaters. It takes adherence to U.S. Department of Energy regulations further by eliminating a tank altogether. The agency requires tanks of 55+ gallons to achieve efficiency rates that require expensive heat pumps. The sensors in Bollente’s electric tankless water heaters keep water at a constant temperature. Efficiency is also maintained by solid state electronics and proprietary software.

Homeowners can monitor and control their water heaters remotely, and even manage and be alerted via smartphone. Wireless apps are available to set the system, monitor all parameters, and receive notifications on a phone from anywhere. Custom settings for power help to achieve even better efficiency and performance. trutankless heaters can also be connected to smart grid and home automation systems. In fact, they are 99 percent efficient, providing hot water at all times but using less energy than tank heaters.

The tankless water heaters also have a self-flushing system and can remain maintenance free for 20 years or more. Therefore, the costs of upkeep are low, and one does not have to worry about replacing the system for quite some time. Millions of old water heaters are dumped into landfills each year. The long-lasting systems from Bollente can help reduce the strain on the environment by keeping reliable, efficient tankless water heaters in homes longer, where they serve a functional purpose that people can depend upon over the long term.

The company is serving a housing market concentrated in warmer areas, in a nation where over eight million water headers are sold. This is important from an investment standpoint, in that the vast majority of building starts and permits cited earlier also represent an extremely high concentration in southern and western regions. Not only does the technology satisfy an increasing demand. It offers competitive pricing for a product that offers annual energy expenditures well below technologies such as conventional electric or gas storage and comparable to solar electric-backup systems.

The company’s industry partnerships for the trutankless line are an important growth driver and include the largest national and regional plumbing equipment distributors across the nation, as well as first-time partnerships with leading national service companies like Mr. Rooter. The international sale of trutankless systems is being managed through a wholly-owned subsidiary, Bollente International, Inc. Outside the U.S., the demand is high in places like Asia, Europe, Australia, and New Zealand, where homeowners are seeing the economic value of tankless water heater systems. The result has been significant growth, with total revenue for the last four quarters markedly outpacing total revenue of the previous four quarters.

For more information, visit the company’s website at www.BollenteCompanies.com

Let us hear your thoughts: Bollente Companies, Inc. Message Board

• SinglePoint positioned for success in the cannabis market through its rapidly expanding portfolio of holdings positions
• Company reduces risk of changing state and federal laws by not touching the plant, but instead focusing on tools and services for the cannabis industry
• Proprietary bitcoin payment solution in development

Specialized holding company SinglePoint, Inc. (OTC: SING) was featured prominently in a recent article (http://dtn.fm/G5jS7) detailing the rapid growth in the North American legal marijuana market. The article explains how several companies, including SinglePoint, are taking advantage of this new market space.

Experts are predicting a 25 percent compound annual growth rate for the cannabis industry; $6.7 billion in retail activity was reported during 2016 in Canada and the United States. The marijuana market in the United States is poised for further explosive growth, and SinglePoint is taking big steps toward dominating the market and reaping the attendant rewards.

SinglePoint is rapidly expanding its portfolio in the cannabis markets with strategic acquisitions of companies offering services to the cannabis industry. With the company’s ongoing strategy of providing tools and services to the cannabis industry without touching the plant, SinglePoint eliminates the risk of being adversely affected by changes in state or federal laws, SinglePoint CEO Greg Lambrecht said in a recent interview (http://dtn.fm/i9O64).

In one of several recent acquisitions of companies involved in the cannabis industry, SinglePoint announced in March the first round of funding to acquire a portion of Jacksam Corp., dba Convectium. Based in Orange County, Convectium provides branding, packaging, equipment and a proprietary oil filling system; the company also sells specialized machines that fill vials with oil and a unique system for filling and packaging vape cartridges and disposable vape pens.

In May, SinglePoint announced its acquisition of a 90 percent share in Discount Indoor Garden Supply (DIGS Hydro), further diversifying the company’s investment portfolio and revenue sourcing. DIGS Hydro provides online products, retail stores, consulting and equipment to the cannabis industry in California, where thousands of cannabis-related businesses and customers are located.

In June, SinglePoint announced an agreement (http://dtn.fm/KRf8u) between DIGS Hydro and Premier Biomedical, Inc. (OTCQB: BIEI) to manufacture Premier’s new CBD Hemp Oil Patch in high quantities. The move is expected to contribute significantly to SinglePoint’s revenue goals.

Federal restrictions have forced the industry to utilize only cash transactions, despite cannabis being legalized for medical or recreational use in 29 states and the District of Columbia. A partnership with First Bitcoin Capital Corp. (OTC: BITCF) allows SinglePoint to move forward with a bitcoin payment solution for the cannabis industry.

Under a joint venture agreement (http://dtn.fm/L1tbQ), the two companies will develop and distribute a payments solution using blockchain technology. First Bitcoin Capital provides industry-leading bitcoin and blockchain technology while SinglePoint has a long history in distribution. The partnership will enable both companies to focus on their core strengths to build the best possible bitcoin payment solution.

For more information, visit the company’s website at www.SinglePoint.com

Let us hear your thoughts: SinglePoint, Inc. Message Board

• The company reported revenues of $589,000 for 2016
• Mergers and acquisitions have enabled AppSwarm to enter the e-commerce, health and education segments
• In-house software development has produced virtual reality products and expanded the app incubation/acceleration program

AppSwarm (OTC: SWRM), a publicly traded technology development and incubation acceleration firm, has experienced a momentum in 2017 that has boosted its ability to acquire applications for any device type. Reaching out to young application developers and entrepreneurs has paid off. The royalty agreements, joint ventures, stock purchase agreements, partnerships, and purchases have expanded the company’s financial resources, while mergers and acquisitions have bolstered software development as well. “The Swarm,” a selective screening process, enables the company to review app ideas and decide which projects to pursue.

Aside from reporting $589,000 in revenues for 2016, the company also reduced its corporate debt. In 2017, it has so far expanded its reach into the e-commerce, health and education markets and grown its in-house software development platforms. These, and the company’s application incubation/acceleration program, have enabled the development of virtual reality products and innovative new software.

Recent acquisitions include that of “Soccers,” acquired from TGTStudios; the game features block-style players and notable soccer teams. Tournaments range in difficulty and consider speed, defense, shooting ability, team morale, and other skill sets. “Komandir,” a virtual reality game, was recently acquired as well, from a prominent Russian development company, while “Avenging Soldiers” from developer Freak X Apps was recently launched. Also, AppSwarm recently launched its own game in the Apple App Store and Google Play Store – “Dead Uncleansed,” a tower defense style mobile game. “Turtles, Huh?” has a main game and various mini games in which players can complete 88 missions as the Turtle or the Penguin. Developed by Turtle Fly, it is designed for iOS platforms.

However, AppSwarm’s recent stream of acquisitions is not limited to games. A PDF document scanner app from TECHNOSYS was recently announced. It uses mobile device cameras to save images of PDF documents, with zoom and color/grayscale/black and white functions.

In addition to reaching into the estimated $7.2 billion virtual reality market, as calculated by Greenlight Insights’ Virtual Reality Industry Report: Spring 2017, AppSwarm has been focused on its in-house and acquired e-commerce development projects. Its compatibility with the company’s incubation system led to the acquisition of Urban Bamboo Designs, launching its website and focusing on the eco-friendliness of the material in many forms of products. Bamboo is strong, lightweight, and flexible, as well as affordable. As such, underdeveloped economies often benefit from its purchase. AppSwarm also stands to benefit from the e-commerce site selling eco-friendly watches, bracelets, sunglasses, phone cases, and décor.

In the first half of 2017, the company has built momentum through mobile app development and acquisitions while expanding its marketing services. Thanks to a lean corporate expenditure profile and profit-based incentive compensation, its strategy continues to be successful.

For more information, visit the company’s website at www.App-Swarm.com

Let us hear your thoughts: AppSwarm, Inc. Message Board

• Proprietary biosynthesis process to produce cannabinoids
• Cannabinoid bioinformatics system that identifies optimal R&D pathways
• Lead candidate targeting billion dollar market

Despite the awe-inspiring shadow cast by the moon on August 21, 2017, there’s no eclipse in sight for InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF). The Vancouver, Canada-based company continues its research and development (R&D) into the therapeutic benefits of cannabinoids, an activity that holds the promise of exceedingly rich reward. Peer valuations have skyrocketed, increasing the likelihood that unicorns may soon appear on the cannabis biotech landscape. With a triad of valuable core assets, it won’t be surprising if, sometime in the future, InMed turns out to be one of them.

InMed Pharmaceuticals has more to offer than the typical drug discovery and development company. Its triple play comprises a proprietary technology based on biosynthesis, a bioinformatics system, and a robust drug development pipeline, any one of which may propel this innovative biotech to success. The company has developed a process to manufacture cannabinoids by applying cannabinoid DNA to Escherichia-coli (E. coli) bacteria. The E. coli DNA is then removed, leaving just the cannabinoid DNA, which can then replicate in a process known as biosynthesis. Biosynthesis is widely employed in the pharmaceutical industry and is used, for example, to manufacture the insulin upon which millions of diabetics rely.

InMed’s bioinformatics system, employing proprietary algorithms, identifies the cannabinoids most likely to have beneficial therapeutic effect in serious diseases with high unmet medical needs. The program integrates data from numerous bioinformatics databases, including a database on the structure of currently approved pharmaceutical products and an extensive proprietary database of over 90 individual cannabinoid drugs found in cannabis. This bioinformatics tool has already identified several therapies, including the company’s two lead pipeline candidates, INM-750 and INM-085.

INM-750 is for the treatment of a rare genetic connective tissue disorder called epidermolysis bullosa (EB). EB is an orphan pediatric disease characterized by extremely fragile skin that affects roughly one out of every 20,000 births in the United States. The condition, which currently has no approved treatment or cure, has been called “The Worst Disease You’ve Never Heard Of” by the Dystrophic Epidermolysis Bullosa Research Association of America. INM-750 works by replacing missing keratins in the skin with specially selected cannabinoids in an effort to modulate the painful manifestations of EB. It has potential global market revenues of approximately $1 billion.

INM-085 targets glaucoma, a leading cause of blindness, according to the Glaucoma Research Foundation. The drug reduces the elevated intra-ocular pressure that is often associated with glaucoma and so holds the promise of providing relief to the more than three million Americans who currently have glaucoma.

Both INM-750 and INM-085 are in the pre-clinical phase, and InMed is taking the lead with the former, which it is hoping to advance to phase I clinical trials in 2018. If all goes well, INM-750 is expected to be in phase III by 2020, setting InMed on a trajectory, if peer comparisons are any indication, to a much higher valuation than its current one of under $50 million. Scioderm, for example, was acquired by Amicus two years ago for $847 million. This acquisition was based on the results of a phase II study of its sole clinical asset Zorblisa, which involved only 42 patients. Zorblisa, for the treatment of EB, is currently in phase III.

InMed’s pipeline is in good hands. Its chief scientific officer is Dr. Sazzad Hossein, who brings more than 20 years of academic and industrial experience in new drug discovery and natural health product development to the C-suite. He was, at one time, group leader and senior scientist at Biotechnology Research Institute of National Research Council Canada, the Government of Canada’s prime biotechnology research organization, where he set up a pharmacology laboratory to evaluate the safety and efficacy of new drugs under development in the areas of cancer and cardiovascular and ocular diseases. He is also the author of more than 40 peer-reviewed papers, primarily in the pharmacology, genetics and nutritional sciences.

InMed’s chief medical officer is Dr. Ado Muhammed. Muhammed joined the company from GW Pharmaceuticals, developer of Sativex, where he was associate medical director, distinguishing InMed as the only biopharmaceutical company in North America with a senior GW team member on its executive team.

For more information, visit the company’s website at www.InMedPharma.com

Let us hear your thoughts: InMed Pharmaceuticals, Inc. Message Board

• Moxian praised for new joint venture strategy to help penetrate key markets in China
• Crystal Equity Research projects Moxian’s sales reaching $2.3 million in FY2018
• Moxian adding three to its board of directors, including Liu Shu Juan, CEO of Shewn International Group, Inc.

Moxian, Inc.’s (NASDAQ: MOXC) price target of $5.25 remains unchanged in the August 15, 2017, update report from Crystal Equity Research LLC (http://dtn.fm/hmV0h), which published its initial report on the company in January 2017. Crystal classified an investment in the company as a ‘speculative buy’ and made positive note of the firm’s joint venture with Shewn International Group in Shanghai. It also said it anticipates revising its revenue estimates for Moxian upward when the Shewn transaction is formalized.

Moxian is an integrated platform operator in the midst of converting its unpaid platforms to paid. Its joint venture with upscale wine distributor Shewn — expected by Crystal Equity to be finalized by the end of September 2017 — calls for Shewn to use Moxian+ Merchant App technology. It uses a UnionPay module processing system and offers Moxian’s Mo-Points redemption plan. In return, Shewn offers Moxian quicker and less costly market penetration and an additional revenue stream. Moxian will earn a fee on Shewn’s digital sales processed on the Moxian+ platform.

“Execution on the Shewn International joint venture should put greater certainty into the Moxian story, providing the foundation for greater investor confidence and a higher valuation of the shares. We view it as an important catalyst for valuation. In our view, the stock provides an interesting play on China’s e-commerce industry” the report said.

Moxian has already signed a memorandum of understanding with Shewn. The research company quoted James Mengdong Tan, CEO of Moxian, as saying that he anticipates 30-40 more joint venture possibilities in the pipeline. Crystal Equity also liked Moxian’s lower cash usage in the quarter ended June 2017, resulting from reduced SG&A costs.

According to an 8K SEC filing on August 16, 2017 (http://dtn.fm/9ho1I), Moxian also had a change in its board of directors. It added Chan Fook Meng, Dr. Yu Lin and Liu Shu Juan to the board. Liu, currently the CEO of Shewn International Group, Inc., is also financial controller of Shanghai Shewn Wine Co. Ltd., the main operating company for Shewn in China. At Moxian, Liu will also serve as Moxian’s executive director.

For more information, visit the company’s website at www.Moxian.com

• Commencing volume manufacturing, allowing ramp-up of distribution and sales
• Partnering with Bitcoin Capital to create proprietary bitcoin payment solution to serve cannabis industry

SinglePoint, Inc. (OTC: SING) continues making great strides in its strategic diversification efforts and has become a compelling and diversified player within the cannabis market. In a recent article, SinglePoint was mentioned among other standout companies that are making their mark in unique ways within the cannabis industry (http://dtn.fm/7zM4s). Shining among these other standouts in the blossoming legal marijuana market, SinglePoint has begun demonstrating its ability to generate revenues through strategic acquisitions in the marijuana space—all without ever touching the plant.

Among its exciting achievements, SinglePoint recently forged an agreement with Premier Biomedical, Inc. (OTCQB: BIEI) to act as a volume supplier in the manufacture of Premier’s new CBD Hemp Oil Skin Patch, which is anticipated to be the first in a line of products stemming from the agreement between the two companies.

Commencing the volume manufacturing of its products will enable Premier to start aggressively expanding its distribution network and increase sales volumes in domestic and foreign markets. For SinglePoint, it is anticipated that this new business will significantly contribute to the company’s revenue goals.

SinglePoint has also been working diligently in its acquisition efforts and inside sales in order to bolster revenues. Among the company’s other recent accomplishments, SinglePoint has joined forces with First Bitcoin Capital Corp. (OTC: BITCF) to create a proprietary bitcoin payment solution to serve U.S. cannabis businesses that are currently “unbankable” due to federal restrictions. The bitcoin solution is being collaboratively developed by the two companies and can be deployed in any point-of-sale machine through a simple download. This will allow marijuana businesses to begin accepting credit and debit card purchases independent of banks and the FDIC, giving cannabis customers a seamless payment experience similar to what they would have in any type of store.

The bitcoin solution will further build on SinglePoint’s track record of offering advanced payment technologies. The company already serves the cannabis industry through its SingleSeed subsidiary (www.SingleSeed.com), which supplies various services to marijuana businesses and has become a hub for dispensaries that are looking for payment processing solutions and other business tools. SingleSeed additionally provides payment processing and text message marketing solutions for marijuana businesses.

Other SinglePoint endeavors include the company’s recent acquisition of Discount Indoor Garden Supply (DIGS), which has positioned the company to be a leader in online products, retail stores, cannabis consulting and equipment in California, serving the thousands of marijuana-related businesses in that state. SinglePoint has acquired 90 percent ownership of DIGS.

SinglePoint also invested in Convectium earlier this year. This California-based provider of equipment, branding and packaging solutions for the cannabis industry developed the very first cartridge and vape pen oil-filling machines offered for wholesale distribution to cannabis dispensaries. Convectium’s 710Shark and 710Seal machines, currently sold through the EquipCanna.com website, are able to fill and package over 100 cartridges of disposable vape pens in only 30 seconds. Additionally, Convectium operates a consumer brand that includes HazeSticks and BlackoutX products.

SinglePoint continues to stand out among companies that are making their mark in the marijuana space through distinctive approaches to this burgeoning market. With so many rivals now looking for a piece of the pie in the marijuana space, SinglePoint’s diversification and unique approaches to profiting from the cannabis boom without actually touching the plant make this company one to watch.

For more information, visit the company’s website at www.SinglePoint.com

Let us hear your thoughts: SinglePoint, Inc. Message Board